Patent · US Active

Targeted immunotolerance

US11466068B2 · kind B2 · utility

0Cited by
110References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2020
Grant dateOct 11, 2022
Priority date—
Expiry dateJul 5, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for conferring site-specific or local immune privilege.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.